Association between metabolic-associated fatty liver disease and risk of cardiometabolic multimorbidity: a disease trajectory analysis in UK Biobank
MAFLD independently elevated the risk of incident CMM, regardless of the baseline CMD status. These findings emphasize the necessity of targeted MAFLD interventions for CMM prevention.
Authors
- Dingliu He (ORCID: https://orcid.org/0009-0006-8486-3242)
- Chunhua Zhao (ORCID: https://orcid.org/0009-0007-2751-430X)
- Zhenyu Jia
- Suyi Liu (ORCID: https://orcid.org/0000-0001-6670-4084)
- Yaqian Gao (ORCID: https://orcid.org/0000-0001-7571-1665)
- Yin Song
- Jianjun Yao
- Yueqing Huang (ORCID: https://orcid.org/0000-0002-3443-5147)
Institutions
- Xuzhou Medical College (CN)
- Anhui Medical University (CN)
- Nantong University (CN)
- Soochow University (CN)
- Zhangjiagang First People's Hospital (CN)
- Suzhou Municipal Hospital (CN)
- Yancheng First People's Hospital (CN)
- Second Affiliated Hospital of Soochow University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine (CN)
- Community Health Center (US)
- First Affiliated Hospital of Soochow University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-06-18
- DOI
- https://doi.org/10.3389/fendo.2025.1585725
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Suzhou Key Medical Center
- Jiangsu Commission of Health